Agomelatine is a melatonin MT1/2 receptor activator that also inhibits 5-HT2C receptors. Agomelatine displays antidepressant, anxiolytic, and hypnotic characteristics and is currently being examined as a marketable antidepressant. Agomelatine improves sleep quality and efficacy and treats insomnia. This compound also enhances neuroplasticity and neurogenesis in the hippocampus and prefrontal cortex.
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...



































